{"transactions":[{"id":825180,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-03-30T21:38:21.000Z","date":"2026-03-26","kind":"sale","planned":true,"acquired":false,"shares":828,"price":21.8932,"value":18127.5696,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"On March 26, 2026, a Restricted Stock Unit (\"RSU\") held by the Reporting Person vested in part. The shares issuable on vesting of the RSU are reported as shares held by the Reporting Person. The award agreement for the RSU provides that the Registrant shall sell a number of shares necessary to cover the Reporting Person's tax withholding responsibility created by the vesting event, with no election made by the Reporting Person. The sales reported on this Form 4 relate exclusively to this mandatory sale upon vesting of the RSU."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.68 to $22.19, inclusive. The reporting person undertakes to provide Neurogene Inc. (the \"Company\"), any securityholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Consist of (a) 5,600 restricted stock units, which vest annually in equal installments on March 26, 2027 and March 26, 2028; and (b) 4,900 restricted stock units which vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":12472,"source":{"system":"sec-edgar","filing":"0001968554-26-000005","document":"wk-form4_1774905406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000196855426000005/wk-form4_1774905406.xml","form_type":"4"}},{"id":884486,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-24T23:49:24.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option represents the right to purchase 29,600 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date."}],"balance_after":29600,"derivative":{"exercise_price":17.64,"expiration_date":"2036-02-20","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0001968554-26-000002","document":"wk-form4_1771976961.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000196855426000002/wk-form4_1771976961.xml","form_type":"4"}},{"id":884485,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-24T23:49:24.000Z","date":"2026-02-20","kind":"grant","planned":false,"acquired":true,"shares":4900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consist of 4,900 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Consist of (a) 8,400 restricted stock units granted on March 26, 2025, which will vest annually in equal installments on March 26, 2026, March 26, 2027 and March 26, 2028; and (b) 4,900 restricted stock units granted on February 20, 2026, which will vest annually in equal installments on February 20, 2027, February 20, 2028 and February 20, 2029, in each case subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":13300,"source":{"system":"sec-edgar","filing":"0001968554-26-000002","document":"wk-form4_1771976961.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000196855426000002/wk-form4_1771976961.xml","form_type":"4"}},{"id":1188763,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2025-03-29T01:28:27.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":50300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 50,300 shares of the Issuer's common stock, one quarter of which will vest on the first anniversary of the grant date with the remaining three quarters vesting in equal monthly installments through the fourth anniversary of the grant date, subject to the Reporting Person's continued provision of service to the Issuer on each vesting date."}],"balance_after":50300,"derivative":{"exercise_price":16.14,"expiration_date":"2035-03-26","underlying":"Common Stock","underlying_shares":50300},"source":{"system":"sec-edgar","filing":"0001404644-25-000021","document":"wk-form4_1743211701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464425000021/wk-form4_1743211701.xml","form_type":"4"}},{"id":1188762,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2025-03-29T01:28:27.000Z","date":"2025-03-26","kind":"grant","planned":false,"acquired":true,"shares":8400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consist of 8,400 restricted stock units, which will vest in three equal annual installments beginning on the first anniversary of the grant date, subject to the Reporting Person's continued provision of services to the Issuer on each vesting date."}],"balance_after":8400,"source":{"system":"sec-edgar","filing":"0001404644-25-000021","document":"wk-form4_1743211701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000140464425000021/wk-form4_1743211701.xml","form_type":"4"}},{"id":1676215,"issuer":{"id":5160,"kind":"organization","name":"Neurogene Inc."},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-01-18T23:48:20.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents the right to purchase 75,000 shares of common stock of the Issuer, of which 25% vests on the first anniversary of the grant date and the remainder vests in equal monthly installments through January 16, 2028, subject to the reporting person's continued service to the Issuer through each applicable vesting date."}],"balance_after":75000,"derivative":{"exercise_price":32.3,"expiration_date":"2034-01-16","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0000950170-24-005531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1404644/000095017024005531/ownership.xml","form_type":"4"}},{"id":1813603,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":false,"shares":4644,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such restricted stock units would have become fully vested on January 1, 2026. The remaining restricted stock units have been automatically cancelled and forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4644},"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813602,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":false,"shares":387,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":387},"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813601,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":false,"shares":1548,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vesting for a portion of the restricted stock units was accelerated and such portion vested and settled on August 3, 2023. The restricted stock units would otherwise have vested and settled as to one half of the restricted stock units on each of January 1, 2024 and January 1, 2025. The remaining restricted stock units have been automatically cancelled and forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1548},"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813600,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":1308,"price":1.39,"value":1818.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The sales reported in the Form 4 were effected pursuant to a mandatory sell to cover arrangement solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":7496,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813599,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":true,"shares":4644,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":8804,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813598,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":109,"price":1.39,"value":151.51,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":4160,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813597,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":true,"shares":387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":4269,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813596,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"sale","planned":true,"acquired":false,"shares":436,"price":1.39,"value":606.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on May 27, 2022 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":3882,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1813595,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-08T01:39:25.000Z","date":"2023-08-03","kind":"exercise","planned":true,"acquired":true,"shares":1548,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":4318,"source":{"system":"sec-edgar","filing":"0000950170-23-039299","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023039299/ownership.xml","form_type":"4"}},{"id":1814657,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-04T20:08:32.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":false,"shares":350,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested and settled in full on August 2, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":350},"source":{"system":"sec-edgar","filing":"0000950170-23-038564","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023038564/ownership.xml","form_type":"4"}},{"id":1814656,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-04T20:08:32.000Z","date":"2023-08-02","kind":"sale","planned":true,"acquired":false,"shares":99,"price":1.31,"value":129.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units."}],"balance_after":2770,"source":{"system":"sec-edgar","filing":"0000950170-23-038564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023038564/ownership.xml","form_type":"4"}},{"id":1814655,"issuer":{"id":5594,"kind":"organization","name":"Q32 Bio Inc.","symbol":"QTTB"},"owners":[{"id":55302,"kind":"person","name":"Jordan Julie","position":1,"cik":"0001968554","reported_name":"Jordan Julie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2023-08-04T20:08:32.000Z","date":"2023-08-02","kind":"exercise","planned":true,"acquired":true,"shares":350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date."}],"balance_after":2869,"source":{"system":"sec-edgar","filing":"0000950170-23-038564","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1661998/000095017023038564/ownership.xml","form_type":"4"}}]}